Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Hyaluronic acid interacting molecules mediated crosstalk between cancer cells and microenvironment from primary tumour to distant metastasis

Xu, Yali, Benedikt, Johannes ORCID: https://orcid.org/0000-0002-9583-2349 and Ye, Lin ORCID: https://orcid.org/0000-0002-0303-2409 2024. Hyaluronic acid interacting molecules mediated crosstalk between cancer cells and microenvironment from primary tumour to distant metastasis. Cancers 16 (10) , 1907. 10.3390/cancers16101907

[thumbnail of cancers-16-01907.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (4MB)

Abstract

Hyaluronic acid (HA) is a prominent component of the extracellular matrix, and its interactions with HA-interacting molecules (HAIMs) play a critical role in cancer development and disease progression. This review explores the multifaceted role of HAIMs in the context of cancer, focusing on their influence on disease progression by dissecting relevant cellular and molecular mechanisms in tumour cells and the tumour microenvironment. Cancer progression can be profoundly affected by the interactions between HA and HAIMs. They modulate critical processes such as cell adhesion, migration, invasion, and proliferation. The TME serves as a dynamic platform in which HAIMs contribute to the formation of a unique niche. The resulting changes in HA composition profoundly influence the biophysical properties of the TME. These modifications in the TME, in conjunction with HAIMs, impact angiogenesis, immune cell recruitment, and immune evasion. Therefore, understanding the intricate interplay between HAIMs and HA within the cancer context is essential for developing novel therapeutic strategies. Targeting these interactions offers promising avenues for cancer treatment, as they hold the potential to disrupt critical aspects of disease progression and the TME. Further research in this field is imperative for advancing our knowledge and the treatment of cancer.

Item Type: Article
Date Type: Published Online
Status: Published
Schools: Engineering
Medicine
Publisher: MDPI
ISSN: 2072-6694
Date of First Compliant Deposit: 5 June 2024
Date of Acceptance: 13 May 2024
Last Modified: 05 Jun 2024 13:15
URI: https://orca.cardiff.ac.uk/id/eprint/169461

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics